Distinguishing Features of Cetuximab and Panitumumab in Colorectal Cancer and Other Solid Tumors
Author:
Publisher
Frontiers Media SA
Subject
Cancer Research,Oncology
Reference137 articles.
1. One target, different effects: a comparison of distinct therapeutic antibodies against the same targets;Shim;Exp Mol Med.,2011
2. ESMO consensus guidelines for the management of patients with metastatic colorectal cancer;Van Cutsem;Ann Oncol.,2016
3. Targeting colorectal cancer with human anti-EGFR monoclonocal antibodies: focus on panitumumab;Kim;Biologics.,2008
4. Resistance to anti-EGFR therapy in colorectal cancer: from heterogeneity to convergent evolution;Misale;Cancer Discov.,2014
Cited by 114 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. The effective combination therapies with irinotecan for colorectal cancer;Frontiers in Pharmacology;2024-02-05
2. Integrated PK/PD Modeling Relates Smoothened Inhibitor Biomarkers to The Heterogeneous Intratumor Disposition of Cetuximab in Pancreatic Cancer Tumor Models;Journal of Pharmaceutical Sciences;2024-01
3. Novel targeting strategies on signaling pathways of colorectal cancer;Colorectal Cancer;2024
4. Recent updates of clinical trials for colorectal cancer;Colorectal Cancer;2024
5. Repurposing EGFR Inhibitors for Oral Cancer Pain and Opioid Tolerance;Pharmaceuticals;2023-11-03
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3